ARNA Genomics
Pioneering early cancer diagnosis through advanced fluid biopsy technology
General Information
BounceWatch is an independent company data service, not affiliated with ARNA Genomics. To contact ARNA Genomics, visit arna.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ARNA Genomics compare?
A PDF of ARNA Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ARNA Genomics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About ARNA Genomics
Business keywords: fluid biopsy, cancer diagnosis, genetic testing, early detection, free-circulating DNA, blood plasma analysis, oncology, precision medicine, Moscow City, startups, investing, biotech research
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $3.50M | 2 |
|
21 Sep 2020 |
| Seed Round | Undisclosed | - |
|
05 Jan 2019 |
ARNA Genomics Alternatives & Competitors
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic...
Leading the Battle Against Lung Cancer through our Early Detection Technology
Advancing precision medicine through next-generation liquid biopsy oncology platform
FAQ About ARNA Genomics
Source: BounceWatch company record for ARNA Genomics, https://bouncewatch.com/company/arna-genomics, updated 10 October 2024. When citing, please name BounceWatch and link this page.
